EVENTS & MEDIA

IN THE NEWS

February 2020 | News

2019: A Transformative Year for Avara, Paving the Way for a Strong 2020.

In 2019, Avara refocused the business on its core capabilities within Oral Solid Dose and Sterile and this resulted in an annual EBITDA of $30.7M (unaudited), at 15% on revenues of $203M, with positive contributions from every Avara facility.

UPCOMING EVENTS

CPhI North America
September 9-11, 2020
Philadelphia, PA

Contract Pharma
September 26-27, 2020
New Brunswick, NJ

CPhI Worldwide
October 13-15, 2020
Milan, Italy

Avara Pharmaceutical Services, Inc.

3300 Marshall Avenue

Norman, OK 73072

T: +1 405 217 7670

E: info@avara.com

© 2020 Avara Pharmaceutical Services, Inc.
All Rights Reserved